Page last updated: 2024-10-22

amiodarone and Vision, Diminished

amiodarone has been researched along with Vision, Diminished in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polak, BC1
Tutein Nolthenius, PA1
Rietveld, E1
Verslegers, W1
De Deyn, PP1

Other Studies

2 other studies available for amiodarone and Vision, Diminished

ArticleYear
[Visual impairment due to optic neuropathy in 2 patients on amiodarone therapy, i.e. ethambutol and isoniazide].
    Nederlands tijdschrift voor geneeskunde, 2001, May-12, Volume: 145, Issue:19

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Female; Humans; Male; Middle Aged

2001
[Visual impairment due to optic neuropathy in 2 patients on amiodarone, and ethambutol and isoniazide therapy, respectively].
    Nederlands tijdschrift voor geneeskunde, 2001, Sep-22, Volume: 145, Issue:38

    Topics: Amiodarone; Anti-Arrhythmia Agents; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Fema

2001